DOJ terminates justice and public safety-focused grants

Author

Image of Brett-Mattson.jpg

Brett Mattson

Legislative Director, Justice & Public Safety
Naomi Freel

Naomi Freel

Legislative Associate

Upcoming Events

Related News

Advocacy

HALT Fentanyl Act signed into law

Department of Justice

Key Takeaways

On April 22, the U.S. Department of Justice’s (DOJ) largest grant-making arm—the Office of Justice Programs (OJP)—abruptly cancelled hundreds of grants awarded to county governments and other local jurisdictions and organizations. Approximately 365 grants have been identified for termination, which were estimated to be valued at $811 million at the time of awarding; it is unclear how much funding remained at the time of termination. The DOJ has indicated that the decision was based on a lack of alignment with the administration’s funding priorities. Affected grantees were given 30 days to appeal, with instructions to demonstrate how the funding termination would directly impact victims.

Read the Notice of Termination

Overview of the grant terminations

The terminated grants supported a wide range of public safety and criminal justice initiatives. Because OJP grants typically operate on a three-year cycle, many of the affected programs were midstream, making the cancellations especially disruptive. Grant recipients were directed to halt all funded activities and stop spending remaining federal funds.

Cancelled programs include efforts related to:

  • Victim services, including support for survivors of domestic violence, sexual assault and human trafficking
  • Mental health crisis response and opioid use interventions
  • Community violence prevention and intervention
  • Reentry services for individuals returning from incarceration
  • Data collection and innovation in local justice systems

Impact on counties

Counties are key implementers of public safety and justice programs, operating 2,875 of our nation’s 3,160 local jails and serving as the primary funders and administrators of justice services including law enforcement, courts, diversion programs and reentry support. The recent DOJ grant terminations may have the following effects:

  • Interrupted County Services: County-run programs addressing victim advocacy, mental health response, opioid intervention and other impacted areas may face reductions in staff, service availability or operational capacity.
  • Challenges in Jail-Based and Reentry Programs: Counties often use federal grants to support in-jail services and transitional programs for individuals exiting incarceration. Terminations may disrupt these efforts and lead to increased recidivism or higher operational costs.
  • Reduced Innovation and Data Work: Grants supporting local data systems or evidence-based practices may no longer receive funding, limiting counties’ ability to identify and implement innovative justice-based practices.
  • Uneven Impact: Rural and under-resourced counties—many of which rely on federal support to provide foundational services—may experience the most significant effects, especially where state funding is limited.

County leaders are currently evaluating local impacts, pursuing appeals where applicable and identifying potential replacement funding sources to maintain continuity in essential justice and public safety programs.

Related News

Image of White-House.jpg
Advocacy

DOJ releases updated list of designated sanctuary jurisdictions

On August 5, the U.S. Department of Justice (DOJ) published an updated list of designated “sanctuary jurisdictions” following the Administration’s Protecting American Communities from Criminal Aliens Executive Order.

583889627
Advocacy

FEMA releases nearly $1 billion in preparedness grants

On August 1, the Federal Emergency Management Agency (FEMA) announced nearly $1 billion in new grant funding to help states, local governments, tribes and territories strengthen disaster preparedness.

Fentanyl
Advocacy

HALT Fentanyl Act signed into law

On July 16, the Halt All Lethal Trafficking of Fentanyl Act (HALT Fentanyl Act) (P.L. 119-26) was signed into law, marking a major turning point in the nation’s response to the opioid epidemic. The bipartisan legislation permanently classifies fentanyl-related substances (FRS) as Schedule I drugs under the Controlled Substances Act, granting law enforcement the authority to combat the growing threat posed by synthetic opioids. The law’s enactment follows years of temporary extensions that placed these substances under federal control on a provisional basis.